4WM
GH icon

49 Wealth Management’s Guardant Health GH Stock Holding History

49 Wealth Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,804
Closed -$221K – 187
2024
Q2 		$221K Buy
+7,804
New +$182K 0.04% 134

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

49 Wealth Management's GH Position: Q3 2024 in Review

49 Wealth Management sold out of Guardant Health (GH) in Q3 2024, closing a stake of 7,804 shares — an estimated $221K sold.

49 Wealth Management first reported a position in GH in Q2 2024 and held it in 1 quarter. The position peaked at $221K in Q2 2024. 270 funds tracked by Wall St. Rank hold GH as of Q3 2024.

  • 49 Wealth Management reported no remaining Guardant Health position as of Q3 2024 after selling out during the quarter.
  • 49 Wealth Management sold 7,804 Guardant Health shares in Q3 2024, an estimated $221K.
  • 49 Wealth Management first reported a position in Guardant Health in Q2 2024 and held it in 1 quarter.
  • 49 Wealth Management's Guardant Health position peaked at $221K in Q2 2024.
  • 270 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on 49 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.